Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spasic

Showing results (381-390 of 386) with videos related to

Pageof 39
Sort By:
You have reached the last page of results.This site can display upto 386 results.
Nature Medicine|June 6, 2022
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trialLacey J Padrón, Deena M Maurer, Mark H O'Hara, et al.
The Journal of Experimental Medicine|August 27, 2024
Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancerApostolia M Tsimberidou, Farah A Alayli, Kwame Okrah, et al.
Nature Biomedical Engineering|March 10, 2026
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancerGregory M Chen, Ankita Jain, David T Gering, et al.
Cancer Cell|February 13, 2019
Mutational Signature Analysis Reveals NTHL1 Deficiency to Cause a Multi-tumor PhenotypeJudith E Grolleman, Richarda M de Voer, Fadwa A Elsayed, et al.
The World Journal of Men'S Health|April 8, 2021
A Global Survey of Reproductive Specialists to Determine the Clinical Utility of Oxidative Stress Testing and Antioxidant Use in Male InfertilityAshok Agarwal, Renata Finelli, Manesh Kumar Panner Selvam, et al.
The New England Journal of Medicine|November 10, 2021
100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report, Damian Smedley, Katherine R Smith, et al.
Pageof 39

Showing results (381-390 of 386) with videos related to

Sort By:
Pageof 39
You have reached the last page of results.This site can display upto 386 results.
Nature Medicine|June 6, 2022
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trialLacey J Padrón, Deena M Maurer, Mark H O'Hara, et al.
The Journal of Experimental Medicine|August 27, 2024
Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancerApostolia M Tsimberidou, Farah A Alayli, Kwame Okrah, et al.
Nature Biomedical Engineering|March 10, 2026
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancerGregory M Chen, Ankita Jain, David T Gering, et al.
Cancer Cell|February 13, 2019
Mutational Signature Analysis Reveals NTHL1 Deficiency to Cause a Multi-tumor PhenotypeJudith E Grolleman, Richarda M de Voer, Fadwa A Elsayed, et al.
The World Journal of Men'S Health|April 8, 2021
A Global Survey of Reproductive Specialists to Determine the Clinical Utility of Oxidative Stress Testing and Antioxidant Use in Male InfertilityAshok Agarwal, Renata Finelli, Manesh Kumar Panner Selvam, et al.
The New England Journal of Medicine|November 10, 2021
100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report, Damian Smedley, Katherine R Smith, et al.
Pageof 39